HFNY2: #419222 v1/04492-0001/093099
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12
(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File
Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number 0-15681
WestMed Venture Partners, L.P.
(Exact name of registrant as specified in its charter)
c/o Medical Venture Holdings, Inc.
CIBC Oppenheimer Tower
World Financial Center
New York, New York 10281
(212)667-5031
(Address, including zip code, and telephone number, including area code, of
registrants principal executive offices)
Units of Limited Partnership Interest
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12h-3(b)(1)(i) [ ] Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice date:
- -0-
Pursuant to the requirements of the Securities Exchange Act of 1934,
WestMed Venture Partners, L.P. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
Date: September 22, 1999 By: WestMed Venture Management, L.P.
Managing General Partner
By: Medical Venture Holdings, Inc.
General Partner
By: /s/_________Ann O. Fusco_______
Name: Ann O. Fusco
Title: Vice President
